The Egyptian Drug Authority (EDA) has signed a memorandum of understanding with the South Africa Health Products Regulatory Authority (SAHPRA) that supports collaboration between the two countries in pharmaceuticals, especially Hepatitis C products.

According to the EDA  statement on Monday, the step aims to “increase the collaboration between the two countries in pharmaceuticals, especially Hepatitis C products and antivirals, biological products, and medical devices.”